All
Andrology
Astronomy
Biochemistry
Bioinformatics
Biology
Biophysics
Biotechnology
Botany
Cardiology
Cell Biology
Chemistry
Dermatology
Ecology
Epidemiology
Evolutionary Biology
General
Genetics
Genomics
Geology
Geriatrics
Gynaecology
Immunology
Informatics
Mathematics
Medicine
Microbiology
Molecular Biology
Neurology
Nutrition
Oncology
Pathology
Pediatrics
Pharmacology
Philosophy
Physics
Physiology
Psychiatry
Psychology
Statistics
Surgery
Toxicology
Urology
Virology
Zoology
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma
(Future Oncology)
21 january 2020 18:00:28
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma
(Future Oncology)
Tweet
Future Oncology, Volume 16, Issue 4, Page 11-19, February 2020.
171 views
Category:
Oncology
Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC? 04-2017)
(Future Oncology)
First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design
(Future Oncology)
Please enable JavaScript to view the
comments powered by Disqus.
blog comments powered by
Disqus
MyJournals.org
The latest issues of all your favorite science journals on one page
Username:
Password:
Register
|
Retrieve
Search:
Google:
Copyright © 2008 - 2024
Indigonet Services B.V.
. Contact:
Tim Hulsen
. Read
here
our privacy notice.
Other websites of Indigonet Services B.V.:
Nieuws
Vacatures
News
Tweets
Nachrichten